Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Insulet Corporation
Insulet makes wearable insulin pumps that people with diabetes stick on their skin to get insulin automatically all day.
Insulet makes a small, tubeless insulin pump called OmniPod. You stick it on your skin, it holds insulin, and a little handheld controller or your phone tells it how much to deliver. That is the whole business: getting insulin into people whose bodies no longer manage it on their own.
The problem it solves is serious. People with type 1 diabetes, and some with type 2, need insulin all day, and the old way meant injections or pumps with tubes running from a device clipped to your belt. OmniPod removes the tubes. You fill a pod the size of a small soap bar, stick it on, and wear it for a few days before swapping it for a fresh one. That convenience is why doctors prescribe it and why patients keep buying it.
The company sells the pods, the controllers, and related supplies, and it makes most of its money from repeat orders. Pods run out every few days and must be replaced, so a patient who likes the system becomes a steady, recurring customer. Insulet also pays to build out manufacturing capacity, because demand has run ahead of its ability to produce. It works closely with diabetes device makers and drugmakers, and it faces competition from other pump makers. Still, its tubeless design has been the key selling point that pulled customers away from older pumps.
Saved answer · last researched 12 Nov 2026